Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,273,814 papers from all fields of science
Search
Sign In
Create Free Account
Gynecologic Oncology
Known as:
gynaecological oncology
, gynecological oncology
, oncology, gynecologic
The branch of oncology that focuses on tumors of the reproductive tract of women.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Revised FIGO staging for carcinoma of the cervix uteri
N. Bhatla
,
J. Berek
,
+8 authors
R. Sankaranarayanan
International journal of gynaecology and…
2019
Corpus ID: 58656013
To revise FIGO staging of carcinoma of the cervix uteri, allowing incorporation of imaging and/or pathological findings, and…
Expand
Review
2016
Review
2016
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
A. Wright
,
Kari Bohlke
,
+14 authors
M. Edelson
Journal of Clinical Oncology
2016
Corpus ID: 24232982
PURPOSE To provide guidance to clinicians regarding the use of neoadjuvant chemotherapy and interval cytoreduction among women…
Expand
Highly Cited
2015
Highly Cited
2015
Guidelines for pre-and intraoperative care in gynecologic / oncology surgery : Enhanced Recovery After Surgery ( ERAS ® ) Society recommendations — Part
G. Nelson
2015
Corpus ID: 13339693
a Department of Gynecologic Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada b Department of Obstetrics, Gynecology…
Expand
Review
2009
Review
2009
Dual-specificity phosphatases: critical regulators with diverse cellular targets.
K. Patterson
,
T. Brummer
,
P. M. O’Brien
,
R. Daly
Biochemical Journal
2009
Corpus ID: 33622687
DUSPs (dual-specificity phosphatases) are a heterogeneous group of protein phosphatases that can dephosphorylate both…
Expand
Highly Cited
2004
Highly Cited
2004
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
G. Fleming
,
V. Brunetto
,
+7 authors
R. Burks
Journal of Clinical Oncology
2004
Corpus ID: 23325608
PURPOSE To determine whether the addition of paclitaxel to doxorubicin plus cisplatin improves overall survival (OS) in women…
Expand
Highly Cited
2001
Highly Cited
2001
Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study.
R. Zaino
,
C. Whitney
,
M. Brady
,
K. Degeest
,
R. Burger
,
R. Buller
Gynecologic Oncology
2001
Corpus ID: 23346290
OBJECTIVES The coexistence of carcinomas of the endometrium and ovary occurs in about 10% of women with ovarian carcinoma. It is…
Expand
Highly Cited
1999
Highly Cited
1999
A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A…
A. Sedlis
,
Brian N. Bundy
,
M. Rotman
,
S. Lentz
,
L. Muderspach
,
R. Zaino
Gynecologic Oncology
1999
Corpus ID: 43167695
OBJECTIVE The objective of this study was to evaluate the benefits and risk of adjuvant pelvic radiotherapy aimed at reducing…
Expand
Highly Cited
1999
Highly Cited
1999
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Peter G. Rose
,
Brian N. Bundy
,
+5 authors
Sam Insalaco
New England Journal of Medicine
1999
Corpus ID: 22219611
BACKGROUND AND METHODS On behalf of the Gynecologic Oncology Group, we performed a randomized trial of radiotherapy in…
Expand
Highly Cited
1989
Highly Cited
1989
Practical gynecologic oncology
J. Berek
,
N. Hacker
1989
Corpus ID: 70783200
Section I: General Principles Biology & Genetics Tumor Markers & Screening Immunology & Biologic Therapy Chemotherapy Radiation…
Expand
Review
1981
Review
1981
Cervical Cancer
A. C. Almendral
,
G. Dallenbach-Hellweg
,
+6 authors
H.-E. Stegner
Current Topics in Pathology
1981
Corpus ID: 1404363
OBJECTIVE To provide physicians and the general public with a responsible assessment of current screening, prevention, and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE